Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 14 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

7%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

10Total
Not Applicable (3)
Early P 1 (1)
P 1 (1)
P 2 (4)
P 3 (1)

Trial Status

Not Yet Recruiting8
Recruiting3
Unknown1
Active Not Recruiting1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 1 completed trials

Clinical Trials (14)

Showing 14 of 14 trials
NCT03085147Phase 1Active Not RecruitingPrimary

A Dye for the Detection of Cancer of the Tongue and Mouth

NCT07371611Phase 3Recruiting

Sintilimab Plus Chemotherapy as Neoadjuvant and Adjuvant Treatment for Locally Advanced Oral Squamous Cell Carcinoma

NCT07306546Not ApplicableNot Yet RecruitingPrimary

Effectiveness of Hydrogen Water Intervention on Acute Oral Inflammation, Oral Microbiota, and Pain Following Free Flap Reconstruction in Patients With Oral Cancer

NCT07137858Phase 2Not Yet RecruitingPrimary

Adebrelimab Combined With Carboplatin and Albumin-bound Taxanol in the Treatment of Resectable Locally Advanced Oral Squamous Cell Carcinoma Cardiac, Randomized, Phase II Exploratory Study

NCT07133958RecruitingPrimary

A Bidirectional Observational Clinical Study of NAIC in the Treatment of Tumor Regression Patterns in LA-OSCC and LA-OPSCC

NCT07079410Phase 2Not Yet RecruitingPrimary

Neoadjuvant and Adjuvant Sintilimab Plus Cetuximab in Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma

NCT05774483Not ApplicableRecruiting

Sentinel Node Biopsy Versus Limited Elective Neck Dissection in Early Cancers of Oral Cavity NoDe Negative

NCT07028918Early Phase 1Not Yet RecruitingPrimary

A Prospective Single-Arm Study(NCLDR)

NCT07015333CompletedPrimary

Case Review of Patients With Betel Nut-induced Oral Cancer Treated With Pembrolizumab and Cetuximab

NCT06861712Phase 2Not Yet RecruitingPrimary

Chemoimmunotherapy With or Without SBRT Before Surgery for Locally Advanced Oral and Oropharyngeal Cancer

NCT06728618Phase 2Not Yet RecruitingPrimary

Preoperative Tislelizumab -Cetuximab - Chemotherapy Followed by Salvage Surgery and Adjuvant Tislelizumab -Cetuximab for Resectable, Locally Recurrent Oral and Oropharyngeal Squamous Cell Carcinoma

NCT06726512Not ApplicableNot Yet Recruiting

Quantitative Margin Assessment Using High-resolution Positron Emission Tomography - Computed Tomograhy

NCT06599801Not Yet RecruitingPrimary

Clinical Outcomes of Thoracodorsal Artery Flap in Oral and Maxillofacial Reconstruction

NCT04270201UnknownPrimary

Determination of ALDH1b1 and ALDH2 Polymorphisms Frequency in the Brazilian Population

Showing all 14 trials

Research Network

Activity Timeline